Non Hodgkin's Lymphoma Risk Tumor Score for Aggressive Lymphoma

Are you evaluating a patient who has just presented with an aggressive malignant non-Hodgkins lymphoma?

Yes

Has the patient had unexplained, recurent or sustained fever, with temperatures greater than 38°C?

Yes

Has the patient experienced drenching night sweats?

Yes

Has the patient experienced unexplained weight loss during the past 6 months?

Yes

Usual body weight

Current body weight

Diameter of largest tumor mass

Is a mediastinal mass visible on a standing PA chest X-ray?

Yes

Serum LDH value

Upper limit of normal reference range for serum LDH

Serum beta-2 microglobulin

Upper limit of normal reference range for beta-2 microglobulin

Ann Arbor tumor stage

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

M.D. Anderson Cancer Center tumor score

Predicted outcome

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Criteria For Diagnosis
- International Prognostic Index (IPI) and Age-Adjusted IPI (aa-IPI) for Non-Hodgkin's Lymphoma
Severity, Prognosis, Stage

Therapy

Options
- International Prognostic Index (IPI) and Age-Adjusted IPI (aa-IPI) for Non-Hodgkin's Lymphoma
Selection
- Prognostic Factors for AIDS-Associated Primary Effusion Lymphoma (PEL)

Monitoring

Response To Therapy
- International Prognostic Index (IPI) and Age-Adjusted IPI (aa-IPI) for Non-Hodgkin's Lymphoma
- Response Criteria for Therapy in Non Hodgkin's Lymphoma

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10

The University of Texas M.D. Anderson Cancer Center's Tumor Score for Aggressive Lymphoma

Purpose: To estimate the prognosis for a patient with an aggressive lymphoma using the M.D. Anderson Cancer Center Tumor Score.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10